Effects of p-Aminosalicylic acid on the neurotoxicity of manganese on the dopaminergic innervation of the cilia of the lateral cells of the gill of the bivalve mollusc, Crassostrea virginica

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 151, Issue 2, 2010, Pages 264-270

  Nelson, Michael ^a   Huggins, Turkesha ^a   Licorish, Roshney ^b   Carroll, Margaret A ^a   Catapane, Edward J ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b KINGSBOROUGH COMMUNITY COLLEGE   (United States)

Author keywords

Ciliary activity; Crassostrea virginica; Dopamine; Gill; Manganism; p Aminosalicylic acid

Indexed keywords

ACETYLSALICYLIC ACID; AMINOSALICYLIC ACID; EDETIC ACID; MANGANESE;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHELATION; CONTROLLED STUDY; CRASSOSTREA VIRGINICA; DOPAMINERGIC ACTIVITY; EUKARYOTIC FLAGELLUM; GILL; INHIBITION KINETICS; INNERVATION; NEUROTOXICITY; NONHUMAN; OYSTER; PRIORITY JOURNAL; STROBOSCOPE;

ANIMALIA; BIVALVIA; CRASSOSTREA VIRGINICA; MOLLUSCA; OSTREIDAE;

EID: 72049093220     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpc.2009.11.005     Document Type: Article

References (58)

1. Aiello E., and Sleigh M.A. The metachronal wave of lateral cilia of Mytilus edulis. J. Cell Biol. 54 (1972) 493-506
2. Andersen M.E., Gearhart J.M., and Clewell III H.J. Pharmacokinetic data needs to support risk assessments for inhaled and ingested manganese. Neurotoxicology 20 (1999) 161-171
3. Baek S.Y., Lee M.J., Jung H.S., Kim H.J., Lee C.R., Yoo C., Lee J.H., Lee H., Yoon C.S., Kim Y.H., Park J., Kim J.W., Jeon B.S., and Kim Y. Effect of manganese exposure on MPTP neurotoxicities. Neurotoxicology 24 (2003) 657-665
4. Barbeau A. Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C Cotzias). Neurotoxicology 5 (1984) 13-35
5. Barbeau A., Inoué N., and Cloutier T. In: Eldridge R., and Fahn S. (Eds). Role of manganese in dystonia. Advances in Neurology vol. 14 (1976), Raven Press, New York 339-352
6. Brenneman K.A., Cattley R.C., Ali S.F., and Dorman D.C. Manganese induced developmental neurotoxicity in the CD rat: is oxidative damage a mechanism of action?. Neurotoxicology 20 (1999) 477-488
7. Calne D.B., Chu N.S., Huang C.C., Lu C.S., and Olanow W. Manganism and idiopathic parkinsonism: similarities and difference. Neurology 44 (1994) 1583-1586
8. Carroll M.A., and Catapane E.J. The nervous system control of lateral ciliary activity of the gill of the bivalve mollusc, Crassostrea virginica. Comp. Biochem. Physiol. A 148 (2007) 445-450
9. Catapane E.J., Stefano G.B., and Aiello E. Pharmacological study of the reciprocal dual innervation of the lateral ciliated gill epithelium by the CNS of Mytilus edulis (Bivalvia). J. Exp. Biol. 74 (1978) 101-113
10. Catapane E.J., Stefano G.B., and Aiello E. Neurophysiological correlates of the dopamine cilio-inhibitory mechanism of Mytilus edulis. J. Exp. Biol. 83 (1979) 315-323
11. Cersosimo M.G., and Koller W.C. The diagnosis of manganese-induced parkinsonism. NeuroToxicology 27 (2006) 340-346
12. Cotzias G.C. Manganese in health and disease. Physiol. Rev. 38 (1958) 503-532
13. Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Br. Ann. Med. Pharmacol. 1 (1837) 41-42
14. Crossgrove J., and Zheng W. Manganese toxicity upon overexposure. Biomedicine 17 8 (2004) 544-553
15. 2-EDTA chelation. Neurotoxicology 21 (2000) 863-866
16. Dobson A.W., Erikson K.M., and Aschner M. Manganese neurotoxicity. Ann. N.Y. Acad. Sci. 1012 (2004) 115-128
17. Donaldson J. The physiopathologic significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 8 (1987) 451-462
18. Eriksson H., Magiste K., Plantin L.O., Fonnum F., Hedstrtm K., Theodorsson G., Norheim E., Kristensson K., Stalberg E., and Heilbronn E. Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation. Arch. Toxicol. 61 (1987) 46-52
19. Erikson K.M., Dobson A.W., Dorman D.C., and Aschner M. Manganese exposure and induced oxidative stress in the rat brain. Sci. Total Environ. 334-335 (2004) 409-416
20. Erikson K.M., Syversen T., Steinnes E., and Aschner M. Globus pallidus: a target brain region for divalent metal accumulation associated with dietary iron deficiency. J. nutr. Biochem. 15 (2004) 335-341
21. Gorell J.M., Rybicki B.A., Cole Johnson C., and Peterson E.L. Occupational metal exposures and the risk of Parkinson's disease. Neuroepidemiology 18 (1999) 303-308
22. Graham D.G. Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology 5 (1984) 83-95
23. 2EDTA. Neurotoxicology 27 (2006) 333-339
24. Hornykiewicz O. Dopamine and extrapyramidal motor function and dysfunction. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 50 (1972) 390-415
25. Huang C.C., Chu N.S., Lu C.S., Chen R.S., and Calne D.B. Long-term progression in chronic Manganism - ten years follow-up. Neurology 50 (1998) 698-700
26. Huang C.C., Chu N.S., Lu C.S., Wang J.D., Tsai J.L., and Tzeng J.L. Chronic manganese intoxication. Arch. Neurol. 46 (1989) 1104-1106
27. Huang C.C., Lu C.S., Chu N.S., Hochberg F., Lilienfeld D., and Olanow W. Progression after chronic manganese exposure. Neurology 43 (1993) 1479-1483
28. Hudnell H.K., Mergler D., and Wittberg R.A. Possible effects of chronic exposure to environmental airborne manganese on neurological function in children. Abstract: Int. Conference on Heavy Metals. (1999), Ann Arbor, Michigan
29. Iregren A. Manganese neurotoxicity in industrial exposures: proof of effects, critical exposure level, and sensitive tests. Neurotoxicology 20 (1999) 315-324
30. Jankovic J. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology 64 (2005) 2021-2028
31. Jiang W., Mo X., Du F., Fu X., Zhu X., Gao H., Xie J., Liao F., Pira E., and Zheng W. Effective treatment of manganese-Induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study. J. Occup. Environ. Med. 48 (2006) 644-649
32. Kaiser J. Manganese: a high octane dispute. Science 300 (2003) 926-928
33. Khandelwal S., Kachru D.N., and Tandon S.K. Chelation in metal intoxication IX. Influence of amino and thiol chelators on excretion of manganese in poisoned rabbits. Toxicol. Letts. 6 (1980) 131-135
34. King C., Myrthil M., Carroll M.A., and Catapane E.J. Effects of p-aminosalicylic acid on the neurotoxicity of manganese and levels of dopamine and serotonin in the nervous system and innervated organs of Crassostrea virginica. In Vivo 29 (2008) 29-34
35. Koller W.C., Lyons K.E., and Truly W. Effect of levodopa treatment for Parkinsonism in welders. A double-blind study. Neurology 62 (2004) 730-733
36. Ky S.Q., Deng H.S., Xie P.Y., and Hu W. A report of two cases of chronic serious manganese poisoning treated with sodium para-aminosalicylic acid. Br. J. Ind. Med. 49 (1992) 66-69
37. Lu C.S., Huang C.C., Chum N.S., and Calne D.B. Levodopa failure in chronic manganism. Neurology 44 (1994) 1600-1602
38. Malanga C.J. Dopaminergic stimulation of frontal ciliary activity in the gill of Mytilus edulis. Comp. Biochem. Physiol. C 51 (1975) 25-34
39. Martin K., Huggins T., King C., Carroll M.A., and Catapane E.J. The neurotoxic effects of manganese on the dopaminergic innervation of the gill of the bivalve mollusc, Crassostrea virginica. Comp. Biochem. Physiol. C 148 (2008) 152-159
40. Meco G., Bonfanti V., Vanacore N., and Fabrizio E. Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate. Scand. J. Work Environ. Health 20 (1994) 301-305
41. Mena I., Court J., Fuenzalida S., Papavasiliou P.S., and Cotzias G.S. Modification of chronic manganese poisoning. N. Engl. J. Med. 282 (1970) 5-10
42. Mena I., Marin O., Fuenzalida S., and Cotzias G.C. Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology 17 (1967) 128-136
43. Murray S., Lovell A., Carroll M.A., and Catapane E.J. Distribution of manganese in the oyster Crassostrea virginica raised in Jamaica Bay, NY and its accumulations in oysters acutely exposed to high levels. Annals of the 2007 SICB Conference (2007)
44. Nagatomo S., Umehara F., Hanada K., Nobuhara Y., Takenaga S., Arimura K., and Osame M. Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J. Neurol. Sci. 162 (1999) 102-105
45. National Academy of Sciences. Medical and biological effects of environmental pollutants: manganese (1973), National Academy Press, Wash. DC 1-101
46. Neff N.H., Barrett R.E., and Costa E. Selective depletion of caudate nucleus dopamine and serotonin during chronic manganese dioxide administration to squirrel monkeys. Experientia 25 (1969) 1140-1141
47. Newland M.C. Animal models of manganese's neurotoxicity. Neurotoxicology 20 (1999) 415-432
48. Olanow C.W. Manganese-induced parkinsonism and Parkinson's disease. Ann. N.Y. Acad. Sci. 1012 (2004) 209-223
49. Ono K., Komai K., and Yamada M. Myoclonic involuntary movement associated with chronic manganese poisoning. J. Neurol. Sci. 199 (2002) 93-96
50. Pal P.K., Samii A., and Calne D.B. Manganese neurotoxicity: a review of clinical features. Neurotoxicology 20 (1999) 227-238
51. Parenti M., Flauto C., Parati E., Vescovi A., and Groppetti A. Manganese neurotoxicity: effects of L-DOPA and pargyline treatments. Brain Res. 367 (1986) 8-13
52. Reidy T.J., Bowler R.M., Rauch S.S., and Pedroza G.I. Pesticide exposure and neuropsychological impairment in migrant farm workers. Arch. Clin. Neuropsychol. l7 (1992) 85-95
53. Rosenstock H.A., Simons D.G., and Meyer J.S. Chronic Manganism. Neurologic and laboratory studies during treatment with levodopa. JAMA 217 (1971) 1354-1358
54. Sistrunk S.C., Ross M.K., and Filipov N.M. Direct effects of manganese compounds on dopamine and its metabolite DOPAC: an in vivo study. Environ. Toxicol. Pharmacol. 23 (2007) 286-296
55. 2. Toxicology 9 (1978) 379-385
56. Tandon S.K., Chandra S.V., Singh J., Husain R., and Seth P.K. Chelation in metal intoxication: I. In vivo effect of chelating agents on liver and testis of manganese administered rats. Environ. Res. 9 (1975) 18-25
57. Vescovi A., Facheris L., Zaffaroni A., Malanca G., and Parati E.A. Dopamine metabolism alterations in a manganese-treated pheochromocytoma cell line (PC12). Toxicology 67 (1991) 129-142
58. Zheng W., Jiang Y., Zhang Y., Jiang W., Wang X., and Cowan D.M. Chelation therapy of manganese intoxication with para-aminosalicylic acid (PAS) in Sprague-Dawley rats. Neurotoxicology 30 (2009) 240-248